EDIT vs TT
Editas Medicine Inc (EDIT) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
EDIT currently screens at market cap $375.2M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the EDIT and TT stock pages for the full models.
Not investment advice.